Stxbp1

Sagi Gidali, one of the founders of Perimeter 81, which was sold for half a billion, won a research innovation award in the US through Rafa’s Moonshot, the non-profit organization he founded to develop drugs for the rare disease STXBP1, which his son Raphael suffers from.